1.654EUR-2.59%Mkt Cap: 279.60M EURP/E: 55.13Last update: 2026-05-29
Lavipharm S.A. engages in the research, development, manufacture, import, marketing, sale, and wholesale of pharmaceutical, cosmetics, and healthcare products to physicians and pharmacists in Greece and internationally. …
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap279.60M EUR
Enterprise Value306.26M EUR
Revenue (TTM)62.58M EUR
Gross Profit30.30M EUR
Net Income (TTM)5.99M EUR
Revenue/Share0.3720 EUR
Last Price1.654 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees285
CountryGR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)55.13
P/E (Forward)—
PEG—
EV/EBITDA23.71
EV/Revenue4.89
P/S4.47
P/B4.95
EPS (TTM)0.03
EPS (Forward)—
52W Range
0.734092% of range1.734
52W High1.734 EUR
52W Low0.7340 EUR
Profitability
Gross Margin48.42%
Oper. Margin20.47%
EBITDA Margin20.64%
Profit Margin9.56%
ROE10.61%
ROA4.60%
Growth
Revenue Growth55.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF6.67M EUR
CapEx (TTM)4.62M EUR
FCF Margin2.63%
FCF Yield0.59%
Net Debt26.67M EUR
Net Debt/EBITDA2.07
Balance Sheet
Debt/Equity0.58
Current Ratio1.21
Quick Ratio0.65
Book Value/Sh0.3340 EUR
Cash/Share0.0360 EUR
Dividends
Fwd Div Rate0.0200 EUR
Trail. Div Rate0.0000 EUR
Div. Yield1.18%
5Y Avg Yield2.38%
Payout Ratio68.49%
Ex-Div DateJul 17, 2025
Pay DateNov 8, 1995
Splits
Last Split1:3
Split DateAug 1, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.169.04M
Float—
Insiders61.85%
Institutions1.38%
Technical
SMA 501.438 (+15.0%)
SMA 2001.075 (+53.8%)
Beta1.00
S&P 52W Chg27.94%
Avg Vol (30d)246.73K
Avg Vol (10d)175.75K
Technical Indicators
RSI (14)67.8
MACD0.0622
MACD Signal0.0631
MACD Hist.-0.0008
BB Upper1.747 EUR
BB Middle1.617 EUR
BB Lower1.488 EUR
BB Width16.04%
ATR (14)0.0687 EUR
Vol Ratio (20d)3.78x